Integrated Clinical Trial Services to Advance Precision Medicine

Global trials for oncology, rare diseases and other complex diseases face unique challenges. Precision partners with you to meet them head-on through our extensive footprint across the globe. We succeed by pairing personalized clinical services with translational medicine excellence, making us the first fully integrated clinical research organization created expressly to help advance the promises of precision medicine.

Integrated Clinical Trial Services to Advance Precision Medicine

Global trials for oncology, rare diseases and other complex diseases face unique challenges. Precision partners with you to meet them head-on through our extensive footprint across the globe. We succeed by pairing personalized clinical services with translational medicine excellence, making us the first fully integrated clinical research organization created expressly to help advance the promises of precision medicine.

The convenience of centralized services

With people across 70+ countries, our team provides comprehensive clinical trial services that streamline and accelerate drug development at a global scale
Clinical Trial Management

Fully integrated biomarker-driven trial management solutions—from study start-up through full-service execution—help accelerate your path to approval.

Clinical Development Strategy

Tailored strategies consider the scientific, regulatory, and commercial factors that shape each trial, mitigating risk and advancing the development pathway.

Clinical Trial Design

Advanced trial design approaches—including basket, umbrella, and adaptive trials—deliver biomarker-driven clinical research. Deep experience in these highly complex trial designs maximizes both insights and efficiency.

Biostatistics

Seasoned biostatisticians and statistical programmers deliver insight into every trial phase, from study design to regulatory submissions, all backed by meticulous documentation and data monitoring.

Clinical Sample Management

Sample inventories from a global network of labs supply real-time processing in 55 countries; consolidated data from central labs, screening labs, and specialty labs with clinical data create actionable reports.

Global Clinical Trial Support

Sample processing labs, clinical trial sites and offices in five continents provide the clinical reach and scale to manage complex global programs.

End-to-end, biomarker-driven clinical trial solutions

Full-service, complex, global clinical research organization services designed to accelerate the path to market

Clinical data science: Trial management and operations empowered by data first

Better visibility, better collaboration, better execution. Targeted solutions we’ve developed based on decades of experience and being at the forefront of modern drug development – focused on the opportunities to deliver the most value for your program
  • Study design and tailored statistical analysis plans
  • Clinical Data Management delivered from more than 70 team members with an average of 12 years of data management experience
  • Clinical biometrics with a 100% EU regulatory agency data acceptance rate
  • Create submission-ready data sets (including CDISC) using a secure 21 CFR Part 11 and GDPR compliant infrastructure
  • Generate AI-derived signatures across integrated multiomic data and explore results in an intuitive, interpretable, and interactive interface
  • Know precisely where every sample is with our virtual sample inventory management (vSIM)

Our clinical trial services support preclinical to phase 4 studies around the world

Phase 2/3
14,000 sites worldwide
Phase 2/3
Over 85,000 patients
Phase 2/3
14,000 sites worldwide
Phase 2/3
Over 85,000 patients

Case Study: Exceeding enrollment expectations in a rescue study: A phase 3 registrational trial in multiple myeloma

Precision was identified by a sponsor to rescue global and US management of a phase 3 registrational trial in relapsed, refractory multiple myeloma patients. This study targeted the enrollment of 780 patients at 155 sites in 20 countries.

The sponsor’s primary motivation for pursuing the shift to Precision from the other contract research organization (CRO) was based on their recognition that clinical research associates (CRAs) with little to no multiple myeloma experience and only minimal monitoring experience had been placed on their study. As a result of inefficiencies in operations, the study’s start-up was delayed.

Discover how our clinical trial services can advance your international clinical trial

Discover how our clinical trial services can advance your international clinical trial

Explore Our Other Areas of Expertise